Brief: Lipocine Announces Publication And Discussion Of LPCN 1148 Manuscript At The Liver Meeting 2024 Editor's Cut Session
18/11/2024 14:40
Nov 18 (Reuters) - Canadian National Railway Co
CNR.TO :
* LIPOCINE ANNOUNCES PUBLICATION AND DISCUSSION OF LPCN 1148
MANUSCRIPT AT THE LIVER MEETING 2024 EDITOR'S CUT SESSION
Source text: ID:nPn2rtWN1a
Further company coverage: CNR.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy